<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0229239.ref007">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Moser</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Kozbial</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Laferl</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Schütz</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Reiberger</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Schwabl</surname>
   <given-names>P</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease</article-title>. 
  <source>Eur J Gastroenterol Hepatol</source>. 
  <year>2018</year>
  <month>3</month>;
  <volume>30</volume>(
  <issue>3</issue>):
  <fpage>291</fpage>–
  <lpage>5</lpage>. 
  <pub-id pub-id-type="doi">10.1097/MEG.0000000000001027</pub-id>
  <?supplied-pmid 29120906?>
  <pub-id pub-id-type="pmid">29120906</pub-id>
 </mixed-citation>
</ref>
